1 Content Group Overview 2 A Purpose-Led Approach 4 Navigating This Report 5 Investment Case 6 Clinical Excellence 10 IHH at a Glance 12 Financial Highlights 14 Operational Highlights 16 Our Sustainability Approach 18 Corporate Milestones 2024 20 Awards and Accreditations Other Information 110 Additional Compliance Information 112 Directors’ Responsibility Statement Financial Statements 114 Directors’ Report 120 Statement by Directors 121 Statutory Declaration 122 Independent Auditors’ Report 125 Statements of Financial Position 127 Statements of Profit or Loss and Other Comprehensive Income 128 Statements of Changes in Equity 134 Statements of Cash Flows 136 Notes to the Financial Statements Additional Corporate Information 237 Analysis of Shareholdings 239 List of Top 30 Largest Shareholders 241 List of Top 10 Properties 243 Notice of Fifteenth Annual General Meeting Form of Proxy Strategic Report 24 Chairman’s Statement 28 Group CEO’s Message 32 Business Strategy 34 Business Model 36 Impact of Value Creation 38 Operations Review 38 Malaysia 39 Singapore 40 Türkiye and Europe 41 India 42 Greater China 43 Parkway Life REIT 43 Laboratories 44 Financial Review 46 Market Outlook 50 Our Material Matters 51 Risk Management 52 Principal Risks Governance 57 Board of Directors 65 Group Management 69 Country Leadership 71 Corporate Governance at a Glance 72 Corporate Governance Overview Statement 89 Nomination and Remuneration Committee Report 94 Audit Committee Report 97 Risk Management Committee Report 99 Statement on Risk Management and Internal Control 107 Investor Relations Report
RkJQdWJsaXNoZXIy NDgzMzc=